GLP-1RAs have been shown to greatly reduce the body weight of obese people with type 2 diabetes.814 The US Food and Drug Administration has approved several different formulations or doses of GLP-1RAs for the treatment of type 2 diabetes: exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and tirzepatide.15 Given the wide variety of GLP-1RA drugs, the differences in pharmacokinetics, efficacy, adverse reaction rates, and dosing requirements of each GLP-1RA need to be evaluated independently.16 Additionally, clinicians need to understand the advantages and disadvantages of each GLP-1RA drug to reach the appropriate clinical decisions
The FDA has approved tirzepatide at doses of 2.5 mg through 15 mg
This vial size offers significant advantages over the more common 5 mg vial
Your body requires vitamin B12 to work more effectively
These may be symptoms of something more serious: temperature of 104F or higher chills chest pain lightheadedness nausea unintentional weight loss Your doctor may make a diagnosis based on your history and a physical exam